Learn More
Medchemexpress LLC N-((6,7-difluoro-1H-benzo[d]imidazol-2-yl)methyl)-9-(3-fluorophenyl)-2-morpholino-9H-purin-6-amine | 1454585-06-8 | MFCD30187527 | 99.7% | 480.45 | C23H19F3N8O | 50 MG

Supplier: Medchemexpress LLC HY10001150MG
SR-3029 is a potent, ATP-competitive inhibitor of casein kinase 1 isoforms CK1δ and CK1ε used for biochemical and pharmacological research. It demonstrates nanomolar inhibition of CK1δ and sub-micromolar inhibition of CK1ε, with reported Ki values and documented activity in both cell-based assays and in vivo xenograft models.
- Potent ATP-competitive inhibition of CK1δ and CK1ε.
- Nanomolar activity suitable for biochemical assays.
- Reported Ki of 97 nM for target binding.
- Validated in cell-based and in vivo xenograft studies.
- High purity to support reliable experimental results.
- Supplied as a stable solid for laboratory use.
By clicking Submit, you acknowledge that you may be contacted by Fisher Scientific in regards to the feedback you have provided in this form. We will not share your information for any other purposes. All contact information provided shall also be maintained in accordance with our Privacy Policy.